MXPA05011862A - Uso de derivados de acido fenoxiacetico para tratamiento de vejiga hiperactiva. - Google Patents

Uso de derivados de acido fenoxiacetico para tratamiento de vejiga hiperactiva.

Info

Publication number
MXPA05011862A
MXPA05011862A MXPA05011862A MXPA05011862A MXPA05011862A MX PA05011862 A MXPA05011862 A MX PA05011862A MX PA05011862 A MXPA05011862 A MX PA05011862A MX PA05011862 A MXPA05011862 A MX PA05011862A MX PA05011862 A MXPA05011862 A MX PA05011862A
Authority
MX
Mexico
Prior art keywords
acid derivatives
phenoxyacetic acid
treating
hyperactive bladder
treating hyperactive
Prior art date
Application number
MXPA05011862A
Other languages
English (en)
Inventor
Masami Kojima
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA05011862(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10320084A external-priority patent/DE10320084A1/de
Priority claimed from DE2003123837 external-priority patent/DE10323837A1/de
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of MXPA05011862A publication Critical patent/MXPA05011862A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se refiere a un nuevo campo de indicacion de derivados de acido fenoxiacetico tal como se describe en la Solicitud de Patente Europea EP 1095932. En la actualidad se ha descubierto que los compuestos descritos en dicha patente, son adecuados para la preparacion de un medicamento para tratar vejiga hiperactiva (vejiga superactiva). Por consiguiente, a traves de estas sustancias activas, se proporciona un metodo para tratar este sindrome urologico.
MXPA05011862A 2003-05-05 2004-03-24 Uso de derivados de acido fenoxiacetico para tratamiento de vejiga hiperactiva. MXPA05011862A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10320084A DE10320084A1 (de) 2003-05-05 2003-05-05 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
DE2003123837 DE10323837A1 (de) 2003-05-23 2003-05-23 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
PCT/JP2004/004048 WO2004098586A1 (en) 2003-05-05 2004-03-24 Use of phenoxyacetic acid derivatives for treating hyperactive bladder

Publications (1)

Publication Number Publication Date
MXPA05011862A true MXPA05011862A (es) 2006-02-17

Family

ID=33420009

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011862A MXPA05011862A (es) 2003-05-05 2004-03-24 Uso de derivados de acido fenoxiacetico para tratamiento de vejiga hiperactiva.

Country Status (26)

Country Link
US (1) US20040229947A1 (es)
EP (1) EP1620085B1 (es)
JP (1) JP4602969B2 (es)
KR (1) KR101052804B1 (es)
AR (1) AR044169A1 (es)
AT (1) ATE401878T1 (es)
AU (1) AU2004236596B2 (es)
BR (1) BRPI0409980A (es)
CA (1) CA2524023C (es)
CL (1) CL2004000952A1 (es)
CY (1) CY1108425T1 (es)
DE (1) DE602004015272D1 (es)
DK (1) DK1620085T3 (es)
ES (1) ES2309513T3 (es)
IL (1) IL171713A (es)
MX (1) MXPA05011862A (es)
MY (1) MY141756A (es)
NZ (1) NZ543347A (es)
PE (1) PE20050524A1 (es)
PL (1) PL1620085T3 (es)
PT (1) PT1620085E (es)
RU (1) RU2342133C2 (es)
SI (1) SI1620085T1 (es)
TW (1) TWI351279B (es)
UY (1) UY28306A1 (es)
WO (1) WO2004098586A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI356699B (en) 2004-11-10 2012-01-21 Kissei Pharmaceutical Agent for treating interstitial cystitis and agent
EP1878719A4 (en) * 2005-04-26 2010-10-06 Kissei Pharmaceutical HYDROXYNOREPHEDRINE DERIVATIVE HYDROCHLORIDE POLYMORPH CRYSTAL
CA2605298A1 (en) * 2005-04-26 2006-11-09 Kissei Pharmaceutical Co., Ltd. Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
CN117695286A (zh) 2017-06-06 2024-03-15 住友制药(苏州)有限公司 使用维贝隆以治疗膀胱过度活动症

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US6720014B1 (en) * 1997-08-13 2004-04-13 Diversa Corporation Phytase-containing foodstuffs and methods of making and using them
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
DE60041110D1 (de) * 1999-11-01 2009-01-29 Sumitomo Chemical Co 6-Hydroxy-5,6-dihydrouracile als Herbizide
EA006022B1 (ru) * 2001-09-13 2005-08-25 Киссеи Фармасьютикал Ко., Лтд. Кристаллы производных гидроксинорэфедрина

Also Published As

Publication number Publication date
DE602004015272D1 (de) 2008-09-04
TWI351279B (en) 2011-11-01
IL171713A (en) 2011-12-29
AR044169A1 (es) 2005-08-24
EP1620085A1 (en) 2006-02-01
SI1620085T1 (sl) 2008-12-31
JP4602969B2 (ja) 2010-12-22
AU2004236596B2 (en) 2010-03-11
CA2524023C (en) 2011-11-22
WO2004098586A1 (en) 2004-11-18
ES2309513T3 (es) 2008-12-16
KR20060009886A (ko) 2006-02-01
NZ543347A (en) 2008-05-30
RU2005137701A (ru) 2006-06-10
CY1108425T1 (el) 2014-04-09
ATE401878T1 (de) 2008-08-15
AU2004236596A1 (en) 2004-11-18
TW200509902A (en) 2005-03-16
EP1620085B1 (en) 2008-07-23
PE20050524A1 (es) 2005-07-07
CA2524023A1 (en) 2004-11-18
MY141756A (en) 2010-06-30
PL1620085T3 (pl) 2009-01-30
US20040229947A1 (en) 2004-11-18
DK1620085T3 (da) 2008-11-24
PT1620085E (pt) 2008-08-07
BRPI0409980A (pt) 2006-05-09
KR101052804B1 (ko) 2011-07-29
JP2006525318A (ja) 2006-11-09
RU2342133C2 (ru) 2008-12-27
CL2004000952A1 (es) 2005-03-04
UY28306A1 (es) 2004-12-31

Similar Documents

Publication Publication Date Title
MY142029A (en) Phenoxyacetic acid derivatives
MXPA05010682A (es) Compuestos novedosos.
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
SE0301009D0 (sv) Novel compounds
EP1961748A3 (en) 2-Hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors
WO2010068810A3 (en) Certain substituted amides, method of making, and method of use thereof
WO2004037789A3 (en) Methylene urea derivatives as raf-kinase inhibitors
YU75903A (sh) Tiohidantoini i njihovo korišćenje u lečenju dijabetisa
EA200401365A1 (ru) Способы лечения илеуса
NO20082496L (no) Pyrazinderivater
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
PT1200103E (pt) Xénon como antagonista de nmda para neuroprotecção
UA86441C2 (ru) (2-гидроксиэтил)триметиламмония тиоктат (холина тиоктат), имеющий гепатопротекторное, гипоаммониемическое и детоксицирующее действие, способ его получения, фармацевтическая композиция на его основе
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
MXPA05010020A (es) Derivados de oxamida.
CY1108425T1 (el) Χρηση παραγωγων φαινοξυοξικου οξεος στην αντιμετωπιση της υπερλειτουργικης ουροδοχου κυστης
SI1730144T1 (sl) Substituirane spojine 1,4,8-triazaspiro(4.5)dekan-2-on
WO2007032009A3 (en) Use of tellurium compounds for treatment of basal cell carcinoma and/or actinic keratosis
WO2004087880A8 (en) Compounds and their use to treat diabetes and related disorders
MXPA05013901A (es) Uso de acido alfa-cetoglutarico para tratamiento de desnutricion o condicion de glucosa alta en plasma.
AU2368802A (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
DE60102084D1 (de) Propanolaminotetraline, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende pharmazeutische zusammensetzungen
TW200505427A (en) A solid oral dosage form of metformin and glyburide and the method of preparation thereof

Legal Events

Date Code Title Description
FG Grant or registration